XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

GOODWILL AND OTHER INTANGIBLE ASSETS (Notes) | 6 Months Ended
--- | ---
Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2023:
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total
| (in millions)
Goodwill as of October 31, 2022 | $ | 1,743 |  |  | $ | 1,953 |  |  | $ | 256 |  |  | $ | 3,952 |
Foreign currency translation impact | 8 |  |  | 2 |  |  | 3 |  |  | 13 |
Goodwill arising from acquisitions and adjustments | — |  |  | 15 |  |  | — |  |  | 15 |
Goodwill as of April 30, 2023 | $ | 1,751 |  |  | $ | 1,970 |  |  | $ | 259 |  |  | $ | 3,980 |
The component parts of other intangible assets as of April 30, 2023 and October 31, 2022 are shown in the table below:
| Other Intangible Assets
| Gross Carrying Amount |  | Accumulated Amortization |  | Net Book Value
| (in millions)
As of October 31, 2022 |  |  |  |  |
Purchased technology | $ | 1,733 |  |  | $ | 1,068 |  |  | $ | 665 |
Trademark/Tradename | 196 |  |  | 148 |  |  | 48 |
Customer relationships | 180 |  |  | 105 |  |  | 75 |
Backlog | 8 |  |  | 8 |  |  | — |
Third-party technology and licenses | 32 |  |  | 9 |  |  | 23 |
Total amortizable intangible assets | 2,149 |  |  | 1,338 |  |  | 811 |
In-Process R&D | 10 |  |  | — |  |  | 10 |
Total | $ | 2,159 |  |  | $ | 1,338 |  |  | $ | 821 |
As of April 30, 2023 |  |  |  |  |
Purchased technology | $ | 1,784 |  |  | $ | 1,118 |  |  | $ | 666 |
Trademark/Tradename | 196 |  |  | 156 |  |  | 40 |
Customer relationships | 182 |  |  | 122 |  |  | 60 |
Backlog | 8 |  |  | 8 |  |  | — |
Third-party technology and licenses | 33 |  |  | 11 |  |  | 22 |
Total amortizable intangible assets | 2,203 |  |  | 1,415 |  |  | 788 |
In-Process R&D | 10 |  |  | — |  |  | 10 |
Total | $ | 2,213 |  |  | $ | 1,415 |  |  | $ | 798 |
During the six months ended April 30, 2023, we recorded additions of $15 million to goodwill and $49 million to other intangible assets in our diagnostics and genomics and life sciences and applied markets segments related to two acquisitions. During the six months ended April 30, 2023, other intangible assets in total increased $2 million due to the impact of foreign currency translation. In general, for U.S. federal tax purposes, goodwill from asset purchases is amortizable; however, any goodwill created as part of a stock acquisition is not deductible. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three and six months ended April 30, 2023 and 2022 we did not identify any triggering events or circumstances which would indicate an impairment of goodwill or indefinite-lived intangible assets. Amortization expense of intangible assets was $38 million and $74 million for three and six months ended April 30, 2023, respectively. Amortization expense of intangible assets was $51 million and $102 million for the three and six months ended April 30, 2022, respectively. Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense: |
(in millions) |
Remainder of 2023 | $ | 74 |
2024 | $ | 133 |
2025 | $ | 109 |
2026 | $ | 80 |
2027 | $ | 78 |
2028 | $ | 71 |
Thereafter | $ | 243 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI https://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration